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Accepted 15 September 2015Anti-p200 pemphigoid, also called anti-laminin-γ1 pemphigoid, is a recently deﬁned entity. First reported in
1996, the incidence is relatively rare, with approximately 70 reports in the literature. Clinical presentation is
heterogeneous, but the disease most commonly mimics bullous pemphigoid with urticarial papules, plaques,
or tense bullae on the trunk or extremities. Described here is a case with additional features of pathergy that
have not yet been reported in the literature.
© 2015 The Authors. Published by Elsevier Inc. on behalf of Women's Dermatologic Society. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).A 58-year-old African American female presented with a 3-week
history of pruritic tense bullae over her hands and neck. There was
no history of psoriasis, inﬂammatory bowel disease, newmedications,
or health status changes preceding the eruption. The patient was
diagnosed with pemphigoid, despite negative direct immunoﬂuores-
cence microscopy, and was placed on topical and oral steroids with
temporary relief. On initial consultation, there were scattered bilateral
4-mm hemorrhagic and noninﬂammatory bullae with slight annular
scale over the dorsal hands. In addition, there were eroded scattered
papules over the anterior and posterior neck (Fig. 1). Antibodies to
BP180 and BP230, as detected by enzyme-linked immunosorbent
assay (EUROIMMUN, Lübeck, Germany), and porphyrin levels were
within normal limits.
Skin biopsy revealed subepidermal blisters with a predominance
of neutrophils, scattered lymphocytes, and eosinophils in the upper
dermis. Direct immunoﬂuorescence microscopy showed continuous
strong linear deposition of immunoglobulin (Ig)G and C3 at the
dermal–epidermal junction. Immunoblot studies detected IgG4
autoantibodies against p200 antigen and the C-terminus of lamin-
in-1γ with no detection of antibodies to type VII collagen extracted
from the dermis, the recombinant NC1 domain of type VII collagen, or
laminin 332 extracted from the extracellular matrix of cultured
human keratinocytes (Groth et al., 2011; Komorowski et al., 2013;
Vaﬁa et al., 2012; Zillikens et al., 1996). For the laminin 332,
recombinant hLAMC1-cterm (amino acids 1364 to 1609; Groth et al.,
2011) and dermal extract (Zillikens et al., 1996) were fractionated by
SDS-PAGE, transferred to nitrocellulosemembrane, and immunoblotted(D. Fivenson).
er Inc. on behalf of Women's Deras reported (Groth et al., 2011). The nitrocellulose membranes were
blocked with 5% dry skim milk. Human sera were diluted in TBST
containing 5% skimmilk powder plus 1% BSA. As a secondary antibody,
horseradish peroxidase–conjugated monoclonal mouse anti-human
IgG4antibody(SouthernBiotech, Birmingham,AL,USA)wasused (Vaﬁa
et al., 2012). The patient developed a single pinpoint pustule at the
venipuncture site and reported never having experienced this type of
reaction to prior needle puncture (Fig. 2). She denied topical treatment
to the area or trauma besides the biopsy.
Thepatient initially responded to oral and topical steroids (prednisone
60 mg/day × 4 weeks, then tapered 10 mg weekly). Doxycycline and
niacinamide were added to the therapeutic regimen with no signiﬁcant
further improvement. After 8 weeks, recurrent disease occurred when
oral steroids were tapered to less than 30 mg per day. Dapsone was
initiated. Subsequently, the patient has been free of skin lesions and off
any oral corticosteroids, and is currently on dapsone 150 mg daily.
Anti-p200 pemphigoid, renamed as anti-laminin γ1 pemphigoid,
has a heterogeneous clinical presentation but most commonlymimics
bullous pemphigoid. The differential diagnosis includes epidermolysis
bullosa acquisita, linear IgA bullous dermatosis, dermatitis herpeti-
formis, or porphyria cutanea tarda and has even been reported
presenting with an erythema gyratum repens–like appearance.
Distinction from these entities is difﬁcult clinically and histologically.
In early lesions, neutrophils may predominate in all conditions
(Dainichi et al., 2009; Dilling et al., 2007; Lazarova et al., 2004;
Monshi et al., 2012; Rose et al., 2007; Shimizu et al., 2012).
Immunoﬂuorescence studies usually demonstrate linear IgG and
C3 deposits along the dermal-epidermal junction in both bullous
pemphigoid and anti-laminin γ1 pemphigoid. In 2009, Dainichi et al.
(2009) identiﬁed the autoantigen in anti-laminin-γ1 pemphigoidmatologic Society. This is an open access article under the CC BY-NC-ND license
Fig. 1. Anti-p200 pemphigoid. Scattered hemorrhagic and noninﬂammatory bullae with
slight annular scale over bilateral dorsal hands.
Fig. 2. Anti-p200 pemphigoid. Solitary pinpoint pustule at the venipuncture site.
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lamina lucida with a molecular weight of 200 kDa, laminin-γ1, clearly
differentiating it from other autoantigens in pemphigoid diseases.
The C-terminus of laminin-γ1 is the immunodominant region of the
protein and activity of the diseasemay bemonitored by enzyme-linked
immunosorbent assay–detecting autoantibodies targeting this domain
(Groth et al., 2011).
Unlike bullous pemphigoid, patients tend to develop anti-p200
pemphigoid at a younger age. Associations with psoriasis vulgaris in
Japanese patients and use of penicillin have been reported, but no
other disease correlations have been documented. However, evidence
of epitope spread and progression to mucosal involvement with the
development of other autoantibodies during the course of the disease
has been reported (Wozniak et al., 2006; Wozniak et al., 2011). Little
information exists regarding long-term outcome of these patients.
One case report has followed a patient for 5 years after diagnosis with
no associated morbidity or mortality (Wozniak et al., 2011).
Pathergic phenomenon is a well-described hypersensitivity reaction
comprised of development of a papule or pustule hours at a site of
traumawithin 24 to 48 hr. This phenomenon is noted in several distinct
dermatological entities, including Beçhet’s, pyoderma gangrenosum,
Sweet’s syndrome, neonateswithDown’s syndrome,myleoproliferative
disorders, non-Hodgkin’s lymphoma, chronicmyeloid leukemia treated
with interferon α, pemphigus vulgaris, and eosinophilic folliculitis.
However, pathergy has not been associated with any of the reported
forms of pemphigoid (Wozniak et al., 2006; Hsu et al., 2005).
Histopathologic studies of pathergy have shown recruitment of
neutrophilswithvariable immunoglobulindepositionand leukocytoclasia
(Baker et al., 2011; Gilhar et al., 1989; Jorizzo et al., 1985). Our patient
declined the biopsy of the pathergy lesion, which resolved during oral
steroid treatment.
The intense neutrophilic inﬁltrate noted in some cases of p200
pemphigoid may explain the presence of pathergy in our case, and its
occurrence in other cases may have been overlooked. We speculate
that, in fact, pathergy may be more common in other neutrophilic
bullous diseases, but is missed because of themany bullae and vesicles
already present at the time of diagnosis. A vesicle triggered by needle
stickmay be overlooked because of themany surrounding lesions. Our
patient’s lesions were acral and did not involve the antecubital fossae,
thus the pathergic lesion was easily detected. Though there is no
histopathologic correlation to prove pathergy versus another form ofKoebnerization in this case, there is also no consensus in the literature
of a distinct dermatopathologic pattern. Akmaz et al. (2000) evaluated
the sensitivity of the histologic pattern in the detection of pathergy
versus clinical detection and determined that clinical evaluation was
as sensitive.
The clinical signiﬁcance of pathergy in our patient is unknown, but
its association may help with earlier diagnosis of this rare immuno-
bullous disease.
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